Motor disorders induced by neuroleptics: a proposed new classification.
D000293:Adolescent; D000328:Adult; D002746:Chlorpromazine / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004422:Dystonia Musculorum Deformans / Q000139:chemically induced; D005163:Factor Analysis, Statistical; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000145:classification*; D010276:Parasympatholytics / Q000009:adverse effects; D012559:Schizophrenia / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome; D013881:Thioridazine / Q000009:adverse effects; D013981:Tic Disorders / Q000139:chemically induced; D014149:Tranquilizing Agents / Q000009:adverse effects*; D014202:Tremor / Q000139:chemically induced; D014273:Triflupromazine / Q000009:adverse effects
D010276:Parasympatholytics; D014149:Tranquilizing Agents; D013881:Thioridazine; D014273:Triflupromazine; D002746:Chlorpromazine